Max Bronstein

President at MGB Consulting

Speaker

Max is a health policy entrepreneur and consultant with 20-years of expertise working in the corporate, government, academic, and non-profit settings. Previously, he led government affairs and patient advocacy at Crinetics Pharmaceuticals, with a focus on rare endocrine diseases. Max served as the Assistant Director for Health Innovation at the White House Office of Science & Technology Policy, where he led initiatives relating to the launch of a new federal agency, ARPA-H. Prior to joining the White House, Max led health policy & corporate affairs at Audentes Therapeutics, a gene therapy company. Previously, Max was the Chief Advocacy & Science Policy Officer at the EveryLife Foundation for Rare Diseases. Max’s writing has appeared in STAT, Pediatrics, Forbes, Nature, and the New England Journal of Medicine. He is the former Director of Science Policy at Research!America where he fought for appropriations research agencies like the NIH and CDC. In 2010, Max founded a non-profit organization, the Journal of Science Policy & Governance, to empower students and young scholars to publish policy-relevant research. He holds a master’s degree in public policy and a certificate in science and technology policy from the Ford School at the University of Michigan in addition to a BA in biology from Ithaca College.